Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global In Vivo CRO Market Size study, by Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, Others) and Regional Forecasts 2022-2028.

  • BIZ4983431
  • 200 Pages
  • July 2022
  • Healthcare
Download Sample    Get Discount   
 
Global In Vivo CRO Market is valued approximately USD 3.9 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.20% over the forecast period 2022-2028. Contract research organizations (CROs) that conduct biopharmaceutical research in vivo are known as in-vivo contract research organizations (CROs). With the increased popularity of biologics over small molecule medications, in-vivo CROs are gaining appeal. Rising demand for sophisticated pharmaceuticals, CROs implementing worldwide standards, and big pharmaceutical firms outsourcing R&D efforts to focus more on their core capabilities are driving market expansion. Furthermore, outsourcing is less expensive than performing an in-house study. This is anticipated to increase demand for in vivo CROs. The demand for a significant number of animal models has quickly expanded across the world in order to ensure the safety and efficacy of novel entities prior to human trials. As a result, the use of these animal models in research centres, which closely resemble the clinical manifestation of SARS-CoV-2, has bolstered market growth. The most prevalent cause of insulin resistance is obesity. According to a National Center for Biotechnology Information (NCBI) research published in 2019, roughly 39% of individuals globally are obese or overweight and at risk of acquiring Type 2 Diabetes Mellitus (T2DM). T2DM is characterized by a gradual reduction in beta-cell activity and insulin resistance. The epidemic has created extraordinary interruption in research and clinical studies over the previous two years. The COVID-19 pandemic was claimed to have interrupted 1,079 clinical studies financed by sponsors, partners, or CROs in November 2021. As of June 2021, oncology was the most affected therapeutic area, accounting for approximately a quarter of all interrupted studies. Clinical trial interruptions would have an influence on the in vivo studies industry. However, sponsors raised CRO outsourced trial spending in 2021 compared to the previous year, according to a recent Outsourcing-Pharma study. The majority of investments are going toward enhancing CRO assistance, particularly technology-based solutions to increase patient access and engagement. Furthermore, a rise in M&A activity by big and mid-sized CROs in 2021 would have a significant post-COVID-19 influence on market growth. Sygnature Discovery, for example, was sold to Rothschild's private equity arm, Five Arrows Principal Investment, and later to Keensight. This illustrates the enthusiasm of investors to invest in early-stage R&D CROs. Furthermore, a rise in M&A activity by big and mid-sized CROs in 2021 would have a significant post-COVID-19 influence on market growth. However, pharmaceutical companies' shifting preference for outsourcing clinical and preclinical trials impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global In Vivo CRO Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. The existence of significant financing in this region influenced research efforts positively. For example, the United States has the largest per capita healthcare spending and funding from government agencies such as the National Institutes of Health (NIH), which promotes research. Over the projection period, Asia Pacific is expected to have the quickest CAGR. The region has a sizable treatment-naive population. It accounts for 53% of the world's urban population and has three times the yearly rate of urbanization as the West. These reasons are driving increase in clinical trials in Asia Pacific.

Major market player included in this report are:

Covance, Inc.

Theorem Clinical Research

WuXi AppTec, Inc.

inVentiv Health

Evotec (US), Inc.

Charles River Laboratories

American Preclinical Services, LLC.

GVK Biosciences Private Limited

Iris Pharma

Pronexus Analytical AB

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Rodent

Non-Rodent

By GLP Type:

Non-GLP

GLP Toxicology

By Indication:

Autoimmune/Inflammation Conditions

Pain Management

Oncology

CNS Conditions

Diabetes

Obesity

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global In Vivo CRO Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. In Vivo CRO Market, by Region, 2020-2028 (USD Billion)

1.2.2. In Vivo CRO Market, by Type, 2020-2028 (USD Billion)

1.2.3. In Vivo CRO Market, by GLP Type, 2020-2028 (USD Billion)

1.2.4. In Vivo CRO Market, by Indication, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global In Vivo CRO Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global In Vivo CRO Market Dynamics

3.1. In Vivo CRO Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Implementation of international standards by CROs

3.1.1.2. Rise in outsourcing of R&D activities by major pharmaceutical companies

3.1.2. Market Challenges

3.1.2.1. pharmaceutical companies' shifting preference for outsourcing clinical and preclinical trials

3.1.3. Market Opportunities

3.1.3.1. Technological improvements in In Vivo CRO

Chapter 4. Global In Vivo CRO Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global In Vivo CRO Market, by Type

6.1. Market Snapshot

6.2. Global In Vivo CRO Market by Type, Performance - Potential Analysis

6.3. Global In Vivo CRO Market Estimates & Forecasts by Type 2018-2028 (USD Billion)

6.4. In Vivo CRO Market, Sub Segment Analysis

6.4.1. Rodent

6.4.2. Non-Rodent

Chapter 7. Global In Vivo CRO Market, by GLP Type

7.1. Market Snapshot

7.2. Global In Vivo CRO Market by GLP Type, Performance - Potential Analysis

7.3. Global In Vivo CRO Market Estimates & Forecasts by GLP Type 2018-2028 (USD Billion)

7.4. In Vivo CRO Market, Sub Segment Analysis

7.4.1. Non-GLP

7.4.2. GLP Toxicology

Chapter 8. Global In Vivo CRO Market, by Indication

8.1. Market Snapshot

8.2. Global In Vivo CRO Market by Indication, Performance - Potential Analysis

8.3. Global In Vivo CRO Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)

8.4. In Vivo CRO Market, Sub Segment Analysis

8.4.1. Autoimmune/Inflammation Conditions

8.4.2. Pain Management

8.4.3. Oncology

8.4.4. CNS Conditions

8.4.5. Diabetes

8.4.6. Obesity

8.4.7. Others

Chapter 9. Global In Vivo CRO Market, Regional Analysis

9.1. In Vivo CRO Market, Regional Market Snapshot

9.2. North America In Vivo CRO Market

9.2.1. U.S. In Vivo CRO Market

9.2.1.1. Type breakdown estimates & forecasts, 2018-2028

9.2.1.2. GLP Type breakdown estimates & forecasts, 2018-2028

9.2.1.3. Indication breakdown estimates & forecasts, 2018-2028

9.2.2. Canada In Vivo CRO Market

9.3. Europe In Vivo CRO Market Snapshot

9.3.1. U.K. In Vivo CRO Market

9.3.2. Germany In Vivo CRO Market

9.3.3. France In Vivo CRO Market

9.3.4. Spain In Vivo CRO Market

9.3.5. Italy In Vivo CRO Market

9.3.6. Rest of Europe In Vivo CRO Market

9.4. Asia-Pacific In Vivo CRO Market Snapshot

9.4.1. China In Vivo CRO Market

9.4.2. India In Vivo CRO Market

9.4.3. Japan In Vivo CRO Market

9.4.4. Australia In Vivo CRO Market

9.4.5. South Korea In Vivo CRO Market

9.4.6. Rest of Asia Pacific In Vivo CRO Market

9.5. Latin America In Vivo CRO Market Snapshot

9.5.1. Brazil In Vivo CRO Market

9.5.2. Mexico In Vivo CRO Market

9.6. Rest of The World In Vivo CRO Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Covance, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Type Summary

10.2.1.5. Recent Developments

10.2.2. Theorem Clinical Research

10.2.3. WuXi AppTec, Inc.

10.2.4. inVentiv Health

10.2.5. Evotec (US), Inc.

10.2.6. Charles River Laboratories

10.2.7. American Preclinical Services, LLC.

10.2.8. GVK Biosciences Private Limited

10.2.9. Iris Pharma

10.2.10. Pronexus Analytical ABss

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global In Vivo CRO Market, report scope

TABLE 2. Global In Vivo CRO Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global In Vivo CRO Market estimates & forecasts by Type 2018-2028 (USD Billion)

TABLE 4. Global In Vivo CRO Market estimates & forecasts by GLP Type 2018-2028 (USD Billion)

TABLE 5. Global In Vivo CRO Market estimates & forecasts by Indication 2018-2028 (USD Billion)

TABLE 6. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 7. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. U.S. In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. U.S. In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 18. U.S. In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 19. Canada In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 20. Canada In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. Canada In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 22. UK In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 23. UK In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. UK In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 25. Germany In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 26. Germany In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. Germany In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 28. RoE In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 29. RoE In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. RoE In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 31. China In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 32. China In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. China In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 34. India In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 35. India In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. India In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 37. Japan In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 38. Japan In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. Japan In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 40. RoAPAC In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 41. RoAPAC In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. RoAPAC In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 43. Brazil In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 44. Brazil In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Brazil In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 46. Mexico In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 47. Mexico In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. Mexico In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 49. RoLA In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 50. RoLA In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. RoLA In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 52. Row In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 53. Row In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. Row In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global In Vivo CRO Market

TABLE 56. List of primary sources, used in the study of global In Vivo CRO Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research